Biggest changeAs defined in the standards established by the Public Company Accounting Oversight Board of the United States, a “material weakness” is a deficiency, or a combination of deficiencies, in internal control over financial reporting such that there is a reasonable possibility that a material misstatement of the company’s annual or interim financial statements will not be prevented or detected on a timely basis. 47 We expect to take a number of measures to address the internal control deficiencies that have been identified including expanding our existing accounting and financial reporting personnel, establishing effective monitoring and oversight controls and engaging an external consulting firm to assist us with assessment of Sarbanes-Oxley compliance requirements and improvement of overall internal controls.
Biggest changeAs defined in the standards established by the Public Company Accounting Oversight Board of the United States, a “material weakness” is a deficiency, or a combination of deficiencies, in internal control over financial reporting such that there is a reasonable possibility that a material misstatement of the company’s annual or interim financial statements will not be prevented or detected on a timely basis. 41 Although we have taken certain measures to address the material weaknesses such as implementing internal policies and procedures related to internal control over financial reporting and hiring additional accounting and financial staff with appropriate public company experience and technical accounting knowledge, we will need to further implement such internal policies and procedures and expand our accounting and financial staff in order to address our material weaknesses.
Since we are still in the initial phase in rolling out our Generation 1.0 and 2.0 SaverOne systems, we cannot forecast our revenue in future periods. 43 Research and Development Expenses, Net We have invested almost all of our efforts and financial resources in the research and development of our SaverOne system which is still in development.
Since we are still in the initial phase in rolling out our Generation 1.0 and 2.0 SaverOne systems, we cannot forecast our revenue in future periods. Research and Development Expenses, Net We have invested almost all of our efforts and financial resources in the research and development of our SaverOne system which is still in development.
We are targeting the global aftermarket automobile market starting with the U.S. and Europe. 42 With respect to our DDPS OEM solution, we plan to integrate it into the vehicle manufacturing process, to be offered directly to customers by the vehicle manufacturer as part of the vehicle.
We are targeting the global aftermarket automobile market starting with the U.S. and Europe. With respect to our DDPS OEM solution, we plan to integrate it into the vehicle manufacturing process, to be offered directly to customers by the vehicle manufacturer as part of the vehicle.
Financing income (expenses), net Financing income, net, for the year ended December 31, 2022 were NIS 4,247,000 (approximately $1,207,000) and resulted mainly from exchange differences due to an increase in the U.S. dollar and new Israeli shekel exchange rate between periods and income from revaluation of derivative warrant liability less direct and incremental issuance costs incurred through the initial public offering in the United States in 2022 allocated to derivative warrant liability.
Financing income, net, for the year ended December 31, 2022 were NIS 4,247,000 (approximately $1,171,000) and resulted mainly from exchange differences due to an increase in the U.S. dollar and new Israeli shekel exchange rate between periods and income from revaluation of derivative warrant liability less direct and incremental issuance costs incurred through the initial public offering in the United States in 2022 allocated to derivative warrant liability.
Operating and Financial Review and Prospectus—Components of Our Results of Operations” and elsewhere in this Annual Report, we are not aware of any trends, uncertainties, demands, commitments or events for the period from January 1, 2022 to December 31, 2022 that are reasonably likely to have a material effect on our total revenues, income, profitability, liquidity or capital resources, or that caused the disclosed financial information to be not necessarily indicative of future operating results or financial condition.
Operating and Financial Review and Prospectus—Components of Our Results of Operations” and elsewhere in this Annual Report, we are not aware of any trends, uncertainties, demands, commitments or events for the period from January 1, 2023 to December 31, 2023 that are reasonably likely to have a material effect on our total revenues, income, profitability, liquidity or capital resources, or that caused the disclosed financial information to be not necessarily indicative of future operating results or financial condition. 43 E.
As a result, if the Company’s assumptions change and different assumptions are used, the expense of a stock-based compensation award could be materially different in the future than what was originally planned for. 50
As a result, if the Company’s assumptions change and different assumptions are used, the expense of a stock-based compensation award could be materially different in the future than what was originally planned for. 44
E. Critical Accounting Estimates We describe our significant accounting policies and estimates in Note 3 to our annual financial statements for the year ended December 31, 2022. We believe that these accounting policies and estimates are critical in order to fully understand and evaluate our financial condition and results of operations.
Critical Accounting Estimates We describe our significant accounting policies and estimates in Note 3 to our annual financial statements for the year ended December 31, 2023. We believe that these accounting policies and estimates are critical in order to fully understand and evaluate our financial condition and results of operations.
For a description of our research and development programs and the amounts that we have incurred over the last two years pursuant to those programs, please see “Item 5. Operating and Financial Review and Prospects— A. Operating Results— Operating Expenses— Research and Development Expenses, net” and “Item 5. Operating and Financial Review and Prospects— A.
Research and development, patents and licenses, etc. For a description of our research and development programs and the amounts that we have incurred over the last two years pursuant to those programs, please see “Item 5. Operating and Financial Review and Prospects— A. Operating Results— Operating Expenses— Research and Development Expenses, net”, “Item 5.
Recently-Issued Accounting Pronouncements Certain recently-issued accounting pronouncements are discussed in Note 2, Summary of Significant Accounting Policies, to our annual financial statements for the year ended December 31, 2022 included in elsewhere in this Annual Report, regarding the impact of the IFRS standards as issued by the IASB that we will adopt in future periods in our financial statements.
Recently-Issued Accounting Pronouncements Certain recently-issued accounting pronouncements are discussed in Note 2, Summary of Material Accounting Policies, to our annual financial statements for the year ended December 31, 2023 included in elsewhere in this Annual Report, regarding the impact of the IFRS standards as issued by the IASB that we will adopt in future periods in our financial statements.
The first is an In Cabin DDPS, which comprises an aftermarket product for vehicles (i.e., vehicles already supplied to customers) that is in a commercial phase and an OEM product targeting vehicle manufacturers which is in development. The second is an ADAS product that detects VRUs that provides warning to the vehicle regarding potential collision.
The first is an In Cabin DDPS which comprises an aftermarket product for vehicles (i.e., vehicles already supplied to customers) that is in a commercial phase and an original equipment manufacturer, or OEM, product targeting vehicle manufacturers which is in development. The second is an ADAS product that detects VRUs and provides warning to the vehicle regarding potential collision.
It does this by detecting the exact location and direction of movement of the VRU via their RF footprint from their cellphone signals, under all visibility conditions. Since the development of our VRU solution targets the vehicle manufacturers (a.k.a. the OEM market) and is still in an early stage, it is too early to estimate the cost of development.
It does this by detecting the exact location, direction of movement and speed of the VRU analysis of their cellphone signals, under all visibility conditions. Since the development of our VRU solution targets the vehicle manufacturers (a.k.a. the OEM market) and is still in an early stage, it is too early to estimate the cost of development.
Our technology is based on our proprietary hardware, software and algorithms, and we believe it has significant advantages over our competitors’ because our solution meets the NHTSA’s guidelines for a complete solution for distracted driving.
Our technology is based on our proprietary hardware, software and algorithms, and we believe it has significant advantages over our competitors’ because our solution meets the National Highway Traffic Safety Administration’s, or NHTSA, guidelines for a complete solution for distracted driving.
We have experienced net losses in every period since the inception of SaverOne. We have incurred losses in each year since our inception, including net losses of approximately NIS 25 million (approximately $7.1 million) and NIS 26.5 million (approximately $7.5 million) for the years ended December 31, 2022 and 2021, respectively.
We have incurred losses in each year since our inception, including net losses of approximately NIS 33.8 million (approximately $9.3 million) NIS 25 million (approximately $7.1 million) and NIS 26.5 million (approximately $7.5 million) for the years ended December 31, 2023, 2022 and 2021, respectively.
We anticipate that our general and administrative expenses will increase in the future as we increase our administrative headcount and infrastructure to support our continued research and development programs and the potential commercialization of our products.
We anticipate that our general and administrative expenses will increase in the future as we increase our administrative headcount and infrastructure to support our continued research and development programs and the potential commercialization of our products as we continue to increase investments to support our growth and as a result of our becoming a public company.
The material weakness related to lack of sufficient internal accounting personnel, insufficient segregation of duties, and lack of sufficient internal controls (including IT general controls, entity level controls and transaction level controls).
The material weaknesses were related to segregation of duties and lack of sufficient internal controls (including IT general controls, entity level controls and transaction level controls).
We recognize research and development expenses as incurred deducted by government grants in respect of a research and development projects received from the IIA which are not reasonably assured that the amount received will not be refunded.
We recognize research and development expenses as incurred deducted by government grants in respect of a research and development projects received from the IIA which are not reasonably assured that the amount received will not be refunded. Selling and Marketing Expenses, Net Selling and marketing expenses in 2023 consisted primarily of marketing our solutions and our sales department costs.
Internal Control Over Financial Reporting In connection with the audit of our financial statements as of December 31, 2022 and 2021, we identified control deficiencies in our financial reporting process that constitute a material weakness for the years ended December 31, 2022 and 2021.
Internal Control Over Financial Reporting In connection with the audit of our financial statements as of December 31, 2023, 2022 and 2021, we identified control deficiencies in our financial reporting process that constitute a material weakness for the years ended December 31, 2023, 2022 and 2021 (which were primarily due to the fact that we were a private company prior to June 2, 2022).
As of March 31, 2023, about 3,200 systems have been ordered (which includes about 800 systems ordered as part of our ongoing Generation 1.0 pilot program and over 2,400 systems purchased in commercial orders by our Generation 1.0 customers) and over 1,700 of these systems have been installed.
As of March 22, 2024, about 4,600 systems have been ordered (which includes about 950 systems ordered as part of our ongoing Generation 1.0 and Generation 2.0 pilot program and about 3,750 systems purchased in commercial orders by our Generation 1.0 and Generation 2.0 customers) and about 3,200 of these systems have been installed.
The table below presents our cash flows for the periods indicated: Year Ended December 31, Year Ended December 31, Year Ended December 31, 2022 2021 2020 NIS thousands Net cash used in operating activities (28,370 ) (23,133 ) (12,390 ) Net cash used in investing activities (5,120 ) (5,197 ) (231 ) Net cash provided by (used in) financing activities 41,972 (611 ) 50,136 Net increase (decrease) in cash and cash equivalents 8,482 (28,941 ) 37,515 For a comparison the year ended December 31, 2022 compared to year ended December 31, 2021, all U.S. dollar amounts below were calculated using the exchange rate reported by the Bank of Israel for December 31, 2022, at the rate of one U.S. dollar per NIS 3.519.
The table below presents our cash flows for the periods indicated: Year Ended December 31, Year Ended December 31, 2023 2022 NIS thousands Net cash used in operating activities (35,020 ) (28,370 ) Net cash provided by (used in) investing activities 9,942 (5,120 ) Net cash provided by financing activities 22,490 41,972 Net increase (decrease) in cash and cash equivalents (2,588 ) 8,482 For a comparison the year ended December 31, 2023 compared to year ended December 31, 2022, all U.S. dollar amounts below were calculated using the exchange rate reported by the Bank of Israel for December 31, 2023, at the rate of one U.S. dollar per NIS 3.6270.
As of December 31, 2022, we had an accumulated deficit of NIS 101.8 million (approximately $28.9 million) and we had comprehensive loss and negative cash flow from operating activity in amounts of NIS 25 million (approximately $7.1 million) and NIS 28.4 million (approximately $8.1 million) for the year ended December 31, 2022, respectively.
As of December 31, 2023, we had an accumulated deficit of NIS 135.6 million (approximately $37.4 million) and we had comprehensive loss and negative cash flow from operating activity in amounts of NIS 33.8 million (approximately $9.3 million) and NIS 35 million (approximately $9.6 million) for the year ended December 31, 2023, respectively.
In the past several years, we believe that public awareness and demand for driver safety technologies has grown substantially. While there are currently many driver assistant products on the market, we believe that the safety of drivers will be substantially improved with our technology.
While there are currently many driver assistant products on the market, we believe that the safety of drivers will be substantially improved with our technology.
The NSC reports that mobile phone use during driving causes approximately 1.6 million traffic accidents annually in the United States alone, leading to the death of approximately 4,600 people and injuring an additional 391,000 people. Moreover, the FMCSA reported that 71% of commercially driven large-truck crashes occurred because of driver distraction.
The National Safety Council, or NSC reports that mobile phone use during driving causes approximately 1.6 million traffic accidents annually in the United States alone, leading to the death of approximately 4,600 people and injuring an additional 391,000 people.
As of December 31, 2022, our operating tax loss carryforwards were approximately NIS 85.1 million (approximately $24.2 million). We anticipate that we will continue to generate tax losses for the foreseeable future and that we will be able to carry forward these tax losses indefinitely to future taxable years.
Income Taxes We have yet to generate taxable income in Israel. As of December 31, 2023, our operating tax loss carryforwards was approximately NIS 108 million (approximately $29.8 million). We anticipate that we will continue to generate tax losses for the foreseeable future and that we will be able to carry forward these tax losses indefinitely to future taxable years.
We are currently in the early commercialization stage and have not yet generated significant revenues from our operations. From inception date and through December 31, 2022, we have not generated significant revenues and we have reported ongoing losses.
For additional information, see “Item 5. Operating and Financial Review and Prospects—Recent Offerings”. We are currently in the early commercialization stage and have not yet generated significant revenues from our operations. From inception date and through December 31, 2023, we have not generated significant revenues and we have reported ongoing losses.
Year Ended December 31, Year Ended December 31, Year Ended December 31, 2022 2021 2020 NIS thousands Revenues 1,193 450 316 Cost of revenues (829 ) (288 ) (258 ) Gross Profit 364 162 58 Operating expenses: Research and development expenses, net (21,490 ) (18,847 ) (10,593 ) Selling and marketing expenses (1,591 ) (2,431 ) (2,399 ) General and administrative expenses (6,492 ) (5,149 ) (4,422 ) Loss from operations (29,209 ) (26,265 ) (17,356 ) Finance income 5,099 3 3,907 Finance expense (852 ) (228 ) (117 ) Finance income (expense), net 4,247 (225 ) 3,790 Net loss (24,962 ) (26,490 ) (13,566 ) For a comparison the year ended December 31, 2022 compared to year ended December 31, 2021, all U.S. dollar amounts below were calculated using the exchange rate reported by the Bank of Israel for December 31, 2022, at the rate of one U.S. dollar per NIS 3.519.
Year Ended December 31, Year Ended December 31, 2023 2022 NIS thousands Revenues 2,720 1,193 Cost of revenues (1,968 ) (829 ) Gross Profit 752 364 Operating expenses: Research and development expenses, net (22,861 ) (21,490 ) Selling and marketing expenses, net (3,787 ) (1,591 ) General and administrative expenses (8,327 ) (6,492 ) Loss from operations (34,223 ) (29,209 ) Finance income 1,607 5,099 Finance expense (1,219 ) (852 ) Finance income (expense), net 388 4,247 Net loss (33,835 ) (24,962 ) For a comparison the year ended December 31, 2023 compared to year ended December 31, 2022, all U.S. dollar amounts below were calculated using the exchange rate reported by the Bank of Israel for December 31, 2023, at the rate of one U.S. dollar per NIS 3.6270.
Net cash used in operating activities Net cash used in operating activities increased by NIS 5,237,000 (approximately $1,488,000), or 23%, to approximately NIS 28,370,000 (approximately $8,062,000) for the year ended December 31, 2022 compared to approximately NIS 23,133,000 (approximately $6,574,000) for the year ended December 31, 2021.
Net cash used in operating activities Net cash used in operating activities increased by NIS 6,650,000 (approximately $1,833,000), or 23%, to NIS 35,020,000 (approximately $9,655,000) for the year ended December 31, 2023 compared to approximately NIS 28,370,000 (approximately $7,822,000) for the year ended December 31, 2022.
The increase resulted mainly from expenses associated with the IPO in the United States in 2022 and costs associated with being a public company traded in the Nasdaq.
The increase resulted mainly from associated with being a public company traded in the Nasdaq, as well as higher insurance expenses.
Operating Results Components of Operating Results Revenues and Cost of Revenues Our total revenue consists of selling our Generation 1.0 SaverOne system and our cost of revenues consists of the direct cost of producing and installing the system. Currently, our business activity is only in Israel.
Operating Results Components of Operating Results Revenues and Cost of Revenues Our total revenue consists of selling our SaverOne system and our cost of revenues consists of the direct cost of producing and installing the system. Currently, our business activity is primarily in Israel while we are expanding our presence abroad through the engagement of various international pilot programs.
As of December 31, 2022, we had an accumulated deficit of NIS 101.8 million (approximately $28.9 million).
As of December 31, 2023, we had an accumulated deficit of NIS 135.3 million (approximately $37.3 million).
Risk Factors—General Risk Factors—We have identified a material weakness in our internal control over financial reporting, and we may not be able to successfully implement remedial measures.” As a company with less than $1.235 billion in revenue for our last fiscal year, we qualify as an “emerging growth company” pursuant to the JOBS Act.
However, we cannot assure you that these measures may fully address the material weaknesses in our internal control over financial reporting or that we may conclude that they have been fully remediated. As a company with less than $1.235 billion in revenue for our last fiscal year, we qualify as an “emerging growth company” pursuant to the JOBS Act.
Risk Factors—General Risk Factors—We have identified a material weakness in our internal control over financial reporting, and we may not be able to successfully implement remedial measures.” However, we cannot assure you that these measures may fully address the material weaknesses in our internal control over financial reporting or that we may conclude that they have been fully remediated.
Risk Factors—General Risk Factors—We have identified a material weakness in our internal control over financial reporting, and we may not be able to successfully implement remedial measures” in our Annual Report.
This increase was mainly the result of new agreements we entered into in 2022 related to our Generation 1.0 solution. Revenues increased by approximately NIS 134 (approximately $43,000), or 42%, to NIS 450,000 (approximately $145,000) for the year ended December 31, 2021, compared to NIS 316,000 (approximately $102,000) for the year ended December 31, 2020.
Revenues Revenues increased by NIS 1,527,000 (approximately $421,000), or 128%, to NIS 2,720,000 (approximately $750,000) for the year ended December 31, 2023, compared to NIS 1,193,000 (approximately $329,000) for the year ended December 31, 2022. This increase was mainly the result of new agreements we entered into during 2023.
Financing expenses, net, for the year ended December 31, 2021 were NIS 225,000 (approximately $64,000) and resulted mainly from bank fees and exchange rate differences. Financing expenses for the year ended December 31, 2021 were NIS 225,000 (approximately $72,000) and resulted mainly from bank fees and exchange rate differences.
Financing income (expenses), net Financing income, net, for the year ended December 31, 2023 were NIS 388,000 (approximately $107,000) and resulted mainly from revaluation of derivative warrant liability, income from exchange rate differences and interest in respect with bank deposits.
This increase resulted mainly from salaries and related expenses and subcontractors, due to an increase in the number of employees, and an increase in research and development activity, mainly related to the development of our Generation 2.0 solution.
This increase resulted mainly from higher payroll expenses and subcontractors costs, due to an increase in research and development activity, mainly related to our continuous effort to develop future products.
As of December 31, 2022, we had NIS 29.3 million (approximately $8.3 million) in cash and cash equivalents and short-term bank deposits.
As of December 31, 2023, we had NIS 17.1 million (approximately $4.7 million) in cash and cash equivalents.
Operating Results— Comparison of the year ended December 31, 2022 to the year ended December 31, 2021— Research and Development Expenses.” D. Trend Information Other than as disclosed in “Item 5.
Operating and Financial Review and Prospects— A. Operating Results— Comparison of the year ended December 31, 2023 to the year ended December 31, 2022— Research and Development Expenses”, and Notes 2 and 3 to our audited financial statements included elsewhere in this Annual Report on Form 20-F. D. Trend Information Other than as disclosed in “Item 5.
This increase was mainly the result of an increase in research and development expenses related to the development of the second generation of our product. 48 Net cash used in investing activities Net cash used in investing activities decreased by NIS 77,000 (approximately $22,000), or 1%, to approximately NIS 5,120,000 (approximately $1,455,000) for the year ended December 31, 2022 compared to NIS 5,197,000 (approximately $1,477,000) for the year ended December 31, 2021.
This increase was mainly the result of an increase in the number of installations made during 2023. 40 Research and development expenses, net Research and development expenses, net increased by NIS 1,371,000 (approximately $378,000), or 6%, to NIS 22,861,000 (approximately $6,303,000) for the year ended December 31, 2023, compared to NIS 21,490,000 (approximately $5,925,000) for the year ended December 31, 2022.
Selling and marketing expenses Selling and marketing expenses decreased by approximately NIS 840,000 (approximately $239,000), or 35%, to approximately NIS 1,591,000 (approximately $452,000) for the year ended December 31, 2022, compared to NIS 2,431,000 (approximately $691,000) for the year ended December 31, 2021. Selling and marketing expenses for the year ended December 31, 2022 included mainly sales department costs.
Selling and marketing expenses, net Selling and marketing expenses increased by NIS 2,196,000 (approximately $605,000), or 138%, to NIS 3,787,000 (approximately $1,044,000) for the year ended December 31, 2023, compared to NIS 1,591,000 (approximately $1,266) for the year ended December 31, 2022.
General and Administrative Expenses General and administrative expenses consist primarily of personnel costs, including share-based compensation related to directors and employees, facility costs, patent application and maintenance expenses, and external professional service costs, including legal, accounting, audit, finance, business development, investor relations and human resource services, and other consulting fees.
As we penetrate new markets, we anticipate that our selling and marketing expenses in 2024 and thereafter will increase as we expand our sales department and invest in the marketing of our solutions. 39 General and Administrative Expenses General and administrative expenses consist primarily of personnel costs, including share-based compensation related to directors and employees, facility costs, insurance costs and maintenance expenses, as well as external professional service costs, including legal, audit, business development and human resource services.
Cost of revenues Cost of sales increased by approximately NIS 541,000 (approximately $154,000), or 188%, to NIS 829,000 (approximately $236,000) for the year ended December 31, 2022, compared to NIS 288,000 (approximately $82,000) for the year ended December 31, 2021. This increase was mainly the result of an increase in the number of installations made in 2022.
Cost of revenues Cost of sales increased by NIS 1,139,000 (approximately $314,000), or 137%, to NIS 1,968,000 (approximately $543,000) for the year ended December 31, 2023, compared to NIS 829,000 (approximately $229,000) for the year ended December 31, 2022.
Research and development expenses, net Research and development expenses, net increased by approximately NIS 2,643,000 (approximately $751,000), or 14%, to approximately NIS 21,490,000 (approximately $6,107,000) for the year ended December 31, 2022, compared to NIS 18,847,000 (approximately $5,356,000) for the year ended December 31, 2021.
General and administrative expenses General and administrative expenses increased by NIS 1,835,000 (approximately $506,000), or 28%, to NIS 8,327,000 (approximately $2,296,000) for the year ended December 31, 2023, compared to approximately NIS 6,492,000 (approximately $1,790) for the year ended December 31, 2022.
This increase was mainly due to investments in bank deposits made in 2021. Net cash provided by financing activities Net cash provided by financing activities for the year ended December 31, 2022 was NIS 41,972,000 (approximately $11,927,000), compared to net cash used in financing activities for the year ended December 31, 2021 totaled NIS 611,000 (approximately $174,000).
Net cash provided by financing activities Net cash provided by financing activities decreased by NIS 19,482,000 (approximately $5,371,000), or 46% to NIS 22,490,000 (approximately $6,201,000) for the year ended December 31, 2023, compared to NIS 41,972,000 (approximately $11,572,000) for the year ended December 31, 2022.
This increase was mainly due to investments in bank deposits made in 2021. Net cash used in investing activities increased by NIS 4,966,000 (approximately $1,597,000), or 2,150%, to approximately NIS 5,197,000 (approximately $1,671,000) for the year ended December 31, 2021 compared to NIS 231,000 (approximately $74,000) for the year ended December 31, 2020.
Net cash provided by (used in) investing activities Net cash provided by investing activities during the year ended December 31, 2023 was NIS 9,942,000 (approximately $2,741,000), compared to 5,120,000 NIS (approximately $1,412,000) used in investing activities during the year ended December 31, 2022.
This increase was mainly due to aggregate net proceeds of NIS 37.3 million (approximately $10.6 million) from our IPO in the United States and net proceeds of NIS 5.1 million (approximately $1.4 million) from private placement.
This decrease was mainly due to aggregate net proceeds of NIS 37.3 million (approximately $10.3 million) from our initial public offering in the United States during the corresponding period last year, partly offset by proceeds received during the year from issuance of ADSs resulted from partial exercise of our equity line with YA. C.
Research and development expenses, net increased by approximately NIS 8,254,000 (approximately $2,654,000), or 78%, to approximately NIS 18,847,000 (approximately $6,060,000) for the year ended December 31, 2021, compared to NIS 10,593,000 (approximately $3,406,000) for the year ended December 31, 2020.
Net loss Net loss increased by NIS 8,873,000 (approximately $2,446,000), or 36%, to NIS 33,835,000 (approximately $9,329,000) for the year ended December 31, 2023, compared to NIS 24,962,000 (approximately $6,882,000) for the year ended December 31, 2022.
Liquidity and Capital Resources Overview From our inception date through December 31, 2022, we raised an aggregate of NIS 132 million (approximately $38 million) in private and public offerings, equity bridge investments and government grants for research and development project received from the IIA.
Liquidity and Capital Resources Overview We have financed our operations since our inception primarily from private and public offerings, equity bridge investment fully converted in equity in previous years, government grants from the IIA and MOE and partial exercise of the equity line and promissory notes received from YA.